Australian perceptions of pertussis and vaccine preventable disease in the setting of asthma and COPD

J. Bayliss (Melbourne, Australia), R. Randhawa (Melbourne, Australia), E. Turriani (Wavre, Belgium), K. Oh (Singapore, Singapore), W. Kandeil (Wavre, Belgium), V. Jenkins (Wavre, Belgium), M. Nissen (Singapore, Singapore)

Source: International Congress 2019 – Airway infection in COPD
Session: Airway infection in COPD
Session type: Thematic Poster
Number: 2891
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Bayliss (Melbourne, Australia), R. Randhawa (Melbourne, Australia), E. Turriani (Wavre, Belgium), K. Oh (Singapore, Singapore), W. Kandeil (Wavre, Belgium), V. Jenkins (Wavre, Belgium), M. Nissen (Singapore, Singapore). Australian perceptions of pertussis and vaccine preventable disease in the setting of asthma and COPD. 2891

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


Factors influencing on influenza vaccination among chronic obstructive pulmonary disease: The Korea national health and nutrition examination survey
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016


Factors affecting attitude towards pneumococcal and influenza vaccination in patients admitting to a pulmonary diseases outpatient clinic
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012

Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005

Can the influenza vaccine response be predicted in COPD patients by clinical parameters?
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015

Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease?
Source: Annual Congress 2003 - COPD: risk factors and course of disease
Year: 2003


Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications
Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives
Year: 2008

The importance of pneumococcal and influenza vaccines in patients with allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005

Clinical efficacy of pneumococcal conjugate vaccine in patients with chronic airway disease
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014


Evolution of influenza vaccination coverages in Spanish patients with asthma or chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004

Pneumococcal vaccination: Effects on exacerbation of COPD
Source: Annual Congress 2013 –COPD treatment
Year: 2013


How reliable are claims of an asthma epidemic amongst Canadian children?
Source: Annual Congress 2010 - Paediatric epidemiology: asthma and associated factors
Year: 2010

Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008

Validity and interpretation of mortality, health service and survey data on COPD and asthma in England
Source: Eur Respir J 2003; 21: 279-286
Year: 2003



GBD 2017 estimates on asthma, COPD and other: challenges to measure respiratory disease worldwide
Source: International Congress 2019 – The Global Burden of Disease, Global Alliance for Chronic Diseases and Forum of International Respiratory Societies and other international initiatives
Year: 2019


The economic burden of respiratory diseases: COPD and asthma
Source: Eur Respir Monogr 2014; 65: 116-124
Year: 2014


Incidence of asthma and COPD in a general population
Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD
Year: 2010

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021
Year: 2021



Factors affecting vaccination rates against influenza in adults with asthma
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020